The Osteosarcoma Institute

Through strategic funding, targeted research priorities, and high-impact partnerships, OSI is advancing osteosarcoma research in hopes of finding better treatments for patients and, ultimately, a cure. Learn more: osinst.org/blog/momentum-…

Meet OSI’s incoming Executive Director, Alli Murdoff. Alli is expanding her long-standing relationship with OSI into a new, full time Executive Director position beginning April 1. Learn more about Alli and the OSI team: #team" target="_blank" rel="nofollow noopener">osinst.org/about/#team.

OSI is pleased to share a recently published perspective paper highlighting considerations for designing clinical trials for patients with relapsed and refractory osteosarcoma. Read the brief online here: doi.org/10.1158/1078-0…

@mat__nova @spike_0124 This is a beautiful tribute to your friend Scott. Thank you for sharing 💛💛💛

hello tezos folks, how do you deal with grief? @spike_0124 and i made an artwork collab about it "i never forgot your empathy" is a tribute to scott's friend, matthew cook, who passed away from osteosarcoma grief can take time to express and can take many forms like art 🙏

Immunotherapy is effective against many cancers but hasn’t been successful in treating osteosarcoma. Two promising areas of study are CAR T cell and natural killer cell therapy. Learn more: osinst.org/blog/immunothe…

BREAKING: Jayden Bailey, a 17-year-old student athlete at Lebanon High School, died after being diagnosed with osteosarcoma, a bone cancer, several years ago. Bailey, a 6-foot-6 junior power forward, was diagnosed with the type of bone cancer in June 2022. His left arm was amputated as a result of the cancer in August 2025. After doctors thought he was cancer-free, the disease spread to his stomach in October 2025. Still, he kept playing basketball and attending classes while inspiring those not only at Lebanon High, but the Tennessee high school basketball community. Bailey was honored by the Lebanon City Council days prior to his death with a proclamation of “Jayden Bailey Day.” He was eventually forced to stop playing and going to school because his body was breaking down, his basketball coach, Jim McDowell said. R.I.P. Jayden Bailey ❤️🙏

After an osteosarcoma diagnosis and leg amputation, Tyler Stowe Robinson lived a full life, with prom, nursing school, time with friends, and even dating. His focus on others inspired his family to fund osteosarcoma research. Read more: osinst.org/blog/tylers-st…

Become an OSI Ambassador and join a community focused on finding a cure for osteosarcoma. Use your unique skills and experiences to advocate for research. Start the journey: #ambassadors" target="_blank" rel="nofollow noopener">osinst.org/ways-to-help/#…

Please join us in wishing a happy 20th anniversary to the QuadW Foundation and help us continue the fight against osteosarcoma. Learn more about ways to get involved here: quadw.org/anniversary

Your legacy can make a difference. Planned giving lets you support osteosarcoma research and honor a loved one through wills, life insurance, or non-cash assets. Learn how your gift gets us closer to the cure we are fighting for. Read more: osinst.org/blog/planned-g…

Join @FDAOncology on Monday, February 23 for a public meeting on Rare Disease Day 2026. Panel 1 at 9:15am ET with Kristin Wessel, MD will spotlight trial design for osteosarcoma and outcomes from OSI's co-sponsored workshop with the FDA. Register via FDA: #event-materials" target="_blank" rel="nofollow noopener">fda.gov/news-events/fd…

On this #WorldCancerDay, help us find a cure for osteosarcoma by making a gift today. 100% of all donations to OSI go directly to osteosarcoma research. Make a difference and stand united against cancer. Donate here: osinst.org/donate

Isidro Cortés-Ciriano, PhD, performed genome sequencing on a tumor and reconstructed its evolution. This discovery will hopefully inform which solutions are most effective in fighting osteosarcoma. osinst.org/blog/cortes-ci…

When osteosarcoma spreads beyond the bone, survival drops from 70% to just 30%. That why OSI is funding research focused on metastatic disease. Join us: osinst.org/donate #Osteosarcoma #MetastaticCancer #CancerResearch #FundTheCure

In 2025, we took #RadicalCollaboration to a whole new level. Together with mission-driven foundations and families turning loss into action, we launched the largest ($15M) and most unified osteosarcoma research effort in North America. Thank you to everyone who gave in 2025. We’re just getting started. #RadicalCollaboration

Positive biomarker data from OS Therapies’ Phase 2b OST-HER2 trial shows interferon gamma pathway activation predicts overall survival in pulmonary metastatic osteosarcoma. Read more from @OncNewsCentral: bit.ly/4qy1S39 $OSTX

Osteosarcoma isn’t one disease. We identify 2 epigenetically defined cell states driven by distinct transcriptional circuits and showing state-specific drug vulnerabilities. @CD_AACR doi.org/10.1158/2159-8… Led by @EuniceLoFuentes w/ @AbsoluteClug

Osteosarcoma investigator Troy A. McEachron, PhD, is mapping the tumor microenvironment using spatial profiling tech. His goal: Learn how to make the environment inhospitable for cancer growth. Learn more: osinst.org/blog/mceachron/

This #CelebrationOfLifeDay, we are honoring osteosarcoma survivors like Carlos, whose strength drives our mission forward. Support the research that fuels moments like this: osinst.org/donate